ヒトワクチンの世界市場 2024-2028

概要

ヒトワクチン市場は2023-2028年に291億米ドル、予測期間中のCAGRは9.49%で成長すると予測されます。

当レポートでは、ヒトワクチン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。小児人口の増加、慢性感染症に対する新規ワクチンのニーズ、政府による公的予防接種プログラムなどが市場を牽引しています。

本調査では、新規ワクチンの研究開発が今後数年間のヒトワクチン市場成長を牽引する主要因のひとつであると分析しています。また、ワクチン送達システムの進歩やナノ粒子ワクチンの市場開拓は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模の把握

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• ヒトワクチンの世界市場 2018-2022
• 投与経路セグメント分析 2018-2022
• エンドユーザーセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：投与経路別

• 市場セグメント
• 比較：投与経路別
• 筋肉内：市場規模と予測 2023-2028
• 皮下：市場規模と予測 2023-2028
• 経口：市場規模と予測 2023-2028
• 市場機会：投与経路別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 小児：市場規模と予測 2023-2028
• 大人：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Astellas Pharma Inc.
• AstraZeneca Plc
• Bavarian Nordic AS
• Bharat Biotech Ltd.
• CSL Ltd.
• Daiichi Sankyo Co. Ltd.
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• Merck and Co. Inc.
• Mitsubishi Chemical Group Corp.
• Moderna Inc.
• Pfizer Inc.
• Sanofi SA
• Serum Institute of India Pvt. Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
• Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Route of Administration
• Exhibits33: Data Table on Comparison by Route of Administration
• Exhibits34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
• Exhibits44: Chart on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Route of Administration ($ billion)
• Exhibits47: Data Table on Market opportunity by Route of Administration ($ billion)
• Exhibits48: Chart on End-user - Market share 2023-2028 (%)
• Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by End-user
• Exhibits51: Data Table on Comparison by End-user
• Exhibits52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
• Exhibits57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
• Exhibits58: Chart on Adults - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by End-user ($ billion)
• Exhibits61: Data Table on Market opportunity by End-user ($ billion)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ billion)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: Astellas Pharma Inc. - Overview
• Exhibits112: Astellas Pharma Inc. - Product / Service
• Exhibits113: Astellas Pharma Inc. - Key news
• Exhibits114: Astellas Pharma Inc. - Key offerings
• Exhibits115: AstraZeneca Plc - Overview
• Exhibits116: AstraZeneca Plc - Product / Service
• Exhibits117: AstraZeneca Plc - Key news
• Exhibits118: AstraZeneca Plc - Key offerings
• Exhibits119: Bavarian Nordic AS - Overview
• Exhibits120: Bavarian Nordic AS - Product / Service
• Exhibits121: Bavarian Nordic AS - Key offerings
• Exhibits122: Bharat Biotech Ltd. - Overview
• Exhibits123: Bharat Biotech Ltd. - Product / Service
• Exhibits124: Bharat Biotech Ltd. - Key news
• Exhibits125: Bharat Biotech Ltd. - Key offerings
• Exhibits126: CSL Ltd. - Overview
• Exhibits127: CSL Ltd. - Business segments
• Exhibits128: CSL Ltd. - Key offerings
• Exhibits129: CSL Ltd. - Segment focus
• Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits131: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits134: Emergent BioSolutions Inc. - Overview
• Exhibits135: Emergent BioSolutions Inc. - Product / Service
• Exhibits136: Emergent BioSolutions Inc. - Key news
• Exhibits137: Emergent BioSolutions Inc. - Key offerings
• Exhibits138: GlaxoSmithKline Plc - Overview
• Exhibits139: GlaxoSmithKline Plc - Business segments
• Exhibits140: GlaxoSmithKline Plc - Key news
• Exhibits141: GlaxoSmithKline Plc - Key offerings
• Exhibits142: GlaxoSmithKline Plc - Segment focus
• Exhibits143: Inovio Pharmaceuticals Inc. - Overview
• Exhibits144: Inovio Pharmaceuticals Inc. - Product / Service
• Exhibits145: Inovio Pharmaceuticals Inc. - Key news
• Exhibits146: Inovio Pharmaceuticals Inc. - Key offerings
• Exhibits147: Merck and Co. Inc. - Overview
• Exhibits148: Merck and Co. Inc. - Business segments
• Exhibits149: Merck and Co. Inc. - Key news
• Exhibits150: Merck and Co. Inc. - Key offerings
• Exhibits151: Merck and Co. Inc. - Segment focus
• Exhibits152: Mitsubishi Chemical Group Corp. - Overview
• Exhibits153: Mitsubishi Chemical Group Corp. - Business segments
• Exhibits154: Mitsubishi Chemical Group Corp. - Key offerings
• Exhibits155: Mitsubishi Chemical Group Corp. - Segment focus
• Exhibits156: Moderna Inc. - Overview
• Exhibits157: Moderna Inc. - Product / Service
• Exhibits158: Moderna Inc. - Key offerings
• Exhibits159: Pfizer Inc. - Overview
• Exhibits160: Pfizer Inc. - Product / Service
• Exhibits161: Pfizer Inc. - Key news
• Exhibits162: Pfizer Inc. - Key offerings
• Exhibits163: Sanofi SA - Overview
• Exhibits164: Sanofi SA - Business segments
• Exhibits165: Sanofi SA - Key news
• Exhibits166: Sanofi SA - Key offerings
• Exhibits167: Sanofi SA - Segment focus
• Exhibits168: Serum Institute of India Pvt. Ltd. - Overview
• Exhibits169: Serum Institute of India Pvt. Ltd. - Product / Service
• Exhibits170: Serum Institute of India Pvt. Ltd. - Key offerings
• Exhibits171: Inclusions checklist
• Exhibits172: Exclusions checklist
• Exhibits173: Currency conversion rates for US$
• Exhibits174: Research methodology
• Exhibits175: Validation techniques employed for market sizing
• Exhibits176: Information sources
• Exhibits177: List of abbreviations

Abstract

The human vaccine market is forecasted to grow by USD 29.1 bn during 2023-2028, accelerating at a CAGR of 9.49% during the forecast period. The report on the human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pediatric population, need for novel vaccines for chronic infections, and public immunization programs funded by governments.

Technavio's human vaccine market is segmented as below:

By Route Of Administration

• Intramuscular
• Subcutaneous
• Oral

By End-user

• Pediatrics
• Adults

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the R and D of novel vaccines as one of the prime reasons driving the human vaccine market growth during the next few years. Also, advancements in vaccine delivery systems and development in nano-particle vaccines will lead to sizable demand in the market.

The report on the human vaccine market covers the following areas:

• Human vaccine market sizing
• Human vaccine market forecast
• Human vaccine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human vaccine market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Group Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., and Sanofi SA. Also, the human vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global human vaccine market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
• 4.2 Route of Administration Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

• 6.1 Market segments
• Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
• 6.2 Comparison by Route of Administration
• Exhibit 32: Chart on Comparison by Route of Administration
• Exhibit 33: Data Table on Comparison by Route of Administration
• 6.3 Intramuscular - Market size and forecast 2023-2028
• Exhibit 34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
• 6.4 Subcutaneous - Market size and forecast 2023-2028
• Exhibit 38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
• 6.5 Oral - Market size and forecast 2023-2028
• Exhibit 42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Oral - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Route of Administration
• Exhibit 46: Market opportunity by Route of Administration ($ billion)
• Exhibit 47: Data Table on Market opportunity by Route of Administration ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 50: Chart on Comparison by End-user
• Exhibit 51: Data Table on Comparison by End-user
• 7.3 Pediatrics - Market size and forecast 2023-2028
• Exhibit 52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
• 7.4 Adults - Market size and forecast 2023-2028
• Exhibit 56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Adults - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by End-user
• Exhibit 60: Market opportunity by End-user ($ billion)
• Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Canada - Market size and forecast 2023-2028
• Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Astellas Pharma Inc.
• Exhibit 111: Astellas Pharma Inc. - Overview
• Exhibit 112: Astellas Pharma Inc. - Product / Service
• Exhibit 113: Astellas Pharma Inc. - Key news
• Exhibit 114: Astellas Pharma Inc. - Key offerings
• 12.4 AstraZeneca Plc
• Exhibit 115: AstraZeneca Plc - Overview
• Exhibit 116: AstraZeneca Plc - Product / Service
• Exhibit 117: AstraZeneca Plc - Key news
• Exhibit 118: AstraZeneca Plc - Key offerings
• 12.5 Bavarian Nordic AS
• Exhibit 119: Bavarian Nordic AS - Overview
• Exhibit 120: Bavarian Nordic AS - Product / Service
• Exhibit 121: Bavarian Nordic AS - Key offerings
• 12.6 Bharat Biotech Ltd.
• Exhibit 122: Bharat Biotech Ltd. - Overview
• Exhibit 123: Bharat Biotech Ltd. - Product / Service
• Exhibit 124: Bharat Biotech Ltd. - Key news
• Exhibit 125: Bharat Biotech Ltd. - Key offerings
• 12.7 CSL Ltd.
• Exhibit 126: CSL Ltd. - Overview
• Exhibit 127: CSL Ltd. - Business segments
• Exhibit 128: CSL Ltd. - Key offerings
• Exhibit 129: CSL Ltd. - Segment focus
• 12.8 Daiichi Sankyo Co. Ltd.
• Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
• 12.9 Emergent BioSolutions Inc.
• Exhibit 134: Emergent BioSolutions Inc. - Overview
• Exhibit 135: Emergent BioSolutions Inc. - Product / Service
• Exhibit 136: Emergent BioSolutions Inc. - Key news
• Exhibit 137: Emergent BioSolutions Inc. - Key offerings
• 12.10 GlaxoSmithKline Plc
• Exhibit 138: GlaxoSmithKline Plc - Overview
• Exhibit 139: GlaxoSmithKline Plc - Business segments
• Exhibit 140: GlaxoSmithKline Plc - Key news
• Exhibit 141: GlaxoSmithKline Plc - Key offerings
• Exhibit 142: GlaxoSmithKline Plc - Segment focus
• 12.11 Inovio Pharmaceuticals Inc.
• Exhibit 143: Inovio Pharmaceuticals Inc. - Overview
• Exhibit 144: Inovio Pharmaceuticals Inc. - Product / Service
• Exhibit 145: Inovio Pharmaceuticals Inc. - Key news
• Exhibit 146: Inovio Pharmaceuticals Inc. - Key offerings
• 12.12 Merck and Co. Inc.
• Exhibit 147: Merck and Co. Inc. - Overview
• Exhibit 148: Merck and Co. Inc. - Business segments
• Exhibit 149: Merck and Co. Inc. - Key news
• Exhibit 150: Merck and Co. Inc. - Key offerings
• Exhibit 151: Merck and Co. Inc. - Segment focus
• 12.13 Mitsubishi Chemical Group Corp.
• Exhibit 152: Mitsubishi Chemical Group Corp. - Overview
• Exhibit 153: Mitsubishi Chemical Group Corp. - Business segments
• Exhibit 154: Mitsubishi Chemical Group Corp. - Key offerings
• Exhibit 155: Mitsubishi Chemical Group Corp. - Segment focus
• 12.14 Moderna Inc.
• Exhibit 156: Moderna Inc. - Overview
• Exhibit 157: Moderna Inc. - Product / Service
• Exhibit 158: Moderna Inc. - Key offerings
• 12.15 Pfizer Inc.
• Exhibit 159: Pfizer Inc. - Overview
• Exhibit 160: Pfizer Inc. - Product / Service
• Exhibit 161: Pfizer Inc. - Key news
• Exhibit 162: Pfizer Inc. - Key offerings
• 12.16 Sanofi SA
• Exhibit 163: Sanofi SA - Overview
• Exhibit 164: Sanofi SA - Business segments
• Exhibit 165: Sanofi SA - Key news
• Exhibit 166: Sanofi SA - Key offerings
• Exhibit 167: Sanofi SA - Segment focus
• 12.17 Serum Institute of India Pvt. Ltd.
• Exhibit 168: Serum Institute of India Pvt. Ltd. - Overview
• Exhibit 169: Serum Institute of India Pvt. Ltd. - Product / Service
• Exhibit 170: Serum Institute of India Pvt. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 171: Inclusions checklist
• Exhibit 172: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 173: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 174: Research methodology
• Exhibit 175: Validation techniques employed for market sizing
• Exhibit 176: Information sources
• 13.5 List of abbreviations
• Exhibit 177: List of abbreviations